Intravitreal injection of steroid was first introduced to prevent inflammatory reaction following retinal detachment surgery. Since then it has been use for different condition with inflammatory process at the back of the eye. However, the side effects of steroids in general made their use limited specially with the last few years introduction anti-endothelial vascular growth factor injection.
Published in | Biomedical Sciences (Volume 5, Issue 3) |
DOI | 10.11648/j.bs.20190503.11 |
Page(s) | 24-26 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2019. Published by Science Publishing Group |
Steroids, Intravitreal, Anti-endothelial, Growth Factor, Uveitis, Cystoid, Macular, Edema
[1] | Machemer R, Sugita G, and Tano Y: Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979; 77: pp. 171-180. |
[2] | Lewis GP, Charteris DG, Sethi CS, et al: Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. Eye 2002; 16: pp. 375-387. |
[3] | Benson SE, Grigoropoulos V, Schlottmann PG, et al: Analysis of the macula with optical coherence tomography after successful surgery for proliferative vitreoretinopathy. Arch Ophthalmol 2005; 123: pp. 1651-1656. |
[4] | Chung EJ, Lee H, and Koh HJ: Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008; 246: pp. 967-974. |
[5] | Lam HD, Lahey JM, Kearney JJ, et al: Young patients with branch retinal vein occlusion: a review of 60 cases. Retina 2010; 30: pp. 1520-1523. |
[6] | Roesel M., Gutfleisch M., Heinz C., et al: Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study. Ophthalmic Res 2009; 42: pp. 81-86. |
[7] | Williams G.A., Haller J.A., Kuppermann B.D., et al: Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol 2009; 147: pp. 1048-1054. |
[8] | Dong Z., Namba K., Kitaichi N., et al: Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation. Jpn J Ophthalmol 2008; 52: pp. 374-379. |
[9] | Scott IU, Ip MS, VanVeldhuisen PC, et al: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009; 127: pp. 1115-1127. |
[10] | Hikichi T, Higuchi M, Matsushita T, et al: Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2014; 98: pp. 195-199. |
APA Style
Emad Selim. (2019). Intravitreal Injections of Steroids. Biomedical Sciences, 5(3), 24-26. https://doi.org/10.11648/j.bs.20190503.11
ACS Style
Emad Selim. Intravitreal Injections of Steroids. Biomed. Sci. 2019, 5(3), 24-26. doi: 10.11648/j.bs.20190503.11
AMA Style
Emad Selim. Intravitreal Injections of Steroids. Biomed Sci. 2019;5(3):24-26. doi: 10.11648/j.bs.20190503.11
@article{10.11648/j.bs.20190503.11, author = {Emad Selim}, title = {Intravitreal Injections of Steroids}, journal = {Biomedical Sciences}, volume = {5}, number = {3}, pages = {24-26}, doi = {10.11648/j.bs.20190503.11}, url = {https://doi.org/10.11648/j.bs.20190503.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.bs.20190503.11}, abstract = {Intravitreal injection of steroid was first introduced to prevent inflammatory reaction following retinal detachment surgery. Since then it has been use for different condition with inflammatory process at the back of the eye. However, the side effects of steroids in general made their use limited specially with the last few years introduction anti-endothelial vascular growth factor injection.}, year = {2019} }
TY - JOUR T1 - Intravitreal Injections of Steroids AU - Emad Selim Y1 - 2019/10/17 PY - 2019 N1 - https://doi.org/10.11648/j.bs.20190503.11 DO - 10.11648/j.bs.20190503.11 T2 - Biomedical Sciences JF - Biomedical Sciences JO - Biomedical Sciences SP - 24 EP - 26 PB - Science Publishing Group SN - 2575-3932 UR - https://doi.org/10.11648/j.bs.20190503.11 AB - Intravitreal injection of steroid was first introduced to prevent inflammatory reaction following retinal detachment surgery. Since then it has been use for different condition with inflammatory process at the back of the eye. However, the side effects of steroids in general made their use limited specially with the last few years introduction anti-endothelial vascular growth factor injection. VL - 5 IS - 3 ER -